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Abstract
Background: People with mesothelioma and their families have palliative care needs throughout the relatively short trajectory of 
their illness.
Aim: To describe the palliative care needs and experiences of people with mesothelioma and their family carers.
Design: Integrative systematic review with narrative synthesis (PROSPERO: CRD42020190115).
Data sources: MEDLINE, CINAHL, PsycINFO and the Cochrane Library were searched for articles published between 01 January 2000 
and 10 May 2020. Articles were included if they presented empirical studies or comprehensive reviews including information about 
the palliative care needs and experiences of people with mesothelioma and their family carers.
Results: The search yielded 508 articles, 14 were included in the analysis. A cross cutting theme of ‘uncertainty’ was identified 
encompassing five themes: (1) organisation and co-ordination of services, (2) communication and information needs, (3) management 
of care needs and high symptom burden, (4) consideration of the impact of seeking compensation and (5) family carer needs. Our 
findings demonstrate that people with mesothelioma want a co-ordinated, team-based approach to palliative care with a named 
point of contact. Whilst carers value and benefit from early referral to specialist palliative care, this does not necessarily reflect the 
outcomes and views of patients.
Conclusion: The evidence base around the palliative care needs and experiences of people with mesothelioma and their carers needs 
to be strengthened. The results of this review support the need to develop a greater understanding about the role non-specialist 
palliative care clinicians’ play in providing generalist palliative care for people with mesothelioma and their carers.
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What is already known about the topic?
•• Mesothelioma is a rare cancer associated with a high symptom burden and limited survival, typically 12 months.
•• The pain and dyspnea associated with mesothelioma are perceived to be difficult to palliate.
•• Early referral to specialist palliative care was not found to improve quality of life or mood for patients with mesotheli-
oma when compared with standard care alone, which could be interpreted to mean that standard care is sufficient.
What this paper adds?
•• People with mesothelioma live with unfathomable uncertainty resulting from the lack of clarity around disease progres-
sion and when death will occur, and consequently expressed a need for clearer information and an accessible contact 
person with oversight of their care.
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Introduction
Mesothelioma is a rare, incurable cancer with a high symp-
tom burden.1 Predominantly a pleural disease affecting the 
lining of the lungs, it can also occur in the peritoneum.2 The 
incidence of mesothelioma varies within and between coun-
tries, with the highest rates seen in Australia and the United 
Kingdom (29 cases per million population),3 and the number 
of deaths estimated to be 38,400 per year globally.4 Most 
cases of the disease are caused by preventable asbestos 
exposure, which usually occurs in the workplace resulting in 
mesothelioma being classified as an industrial disease.5,6
People with mesothelioma experience a range of debil-
itating symptoms including pain, breathlessness, cough, 
fatigue, sweating and weight loss, as well as anxiety and 
low mood.7 There are currently no curative treatments for 
mesothelioma, but medicine, surgery and radiotherapy 
can help to improve survival and palliate symptoms.8 The 
main source of support for people with mesothelioma are 
their family and friends.9 Family carers bear a significant 
emotional and physical burden when caring for people 
with mesothelioma.10
Mesothelioma typically progresses rapidly and the 
majority of people with the disease will die within a year 
of diagnosis.11 Consequently, people with mesothelioma 
and their families have palliative care needs throughout 
the relatively short trajectory of their illness, from diagno-
sis to the end of life.12 There is a perception that the pain 
and breathlessness experienced by people with mesothe-
lioma are sometimes difficult to palliate.13 The British 
Thoracic Society and the European Respiratory Society 
highlight the importance of palliative care provision to 
manage the symptoms of mesothelioma and offer emo-
tional, psychological and spiritual support.14,15
There is evidence that specialist palliative care improves 
the quality of life of patients with palliative care needs aris-
ing from a wide range of different life limiting conditions, 
and at the same time reduces health system costs and 
resource utilisation.16 However, a 2019 multicentre ran-
domised controlled trial in the UK and Australia has shown 
that early routine specialist palliative care for patients 
recently diagnosed with malignant pleural mesothelioma 
does not have any additional impacts on quality of life over 
standard care.17 In this trial, early specialist palliative care 
appears to have been trialled with people with mesotheli-
oma in response to the finding that the intervention was 
beneficial in similar populations.16 However, there is limited 
discussion of what the palliative care needs of people with 
mesothelioma might be, and how these may differ from 
patients with other malignancies.17 Healthcare needs are a 
complex concept commonly defined as the capacity to ben-
efit.18 Where the healthcare needs of a patient population 
are determined using a top-down approach, which relies 
too heavily on what a few people perceive to be the needs 
of that population rather than what they actually are we risk 
providing ineffective and costly intervention, as demon-
strated by this trial.17,18 Consequently the authors of this 
study propose that we need a better understanding of the 
palliative care needs and experiences of people with meso-
thelioma and their family carers in order to inform decisions 
on what services need to be in place, who should provide 
them and at what time they should be offered. Compared 
with other cancers, the palliative care needs and experi-
ences of people with mesothelioma pose unique complexi-
ties due to the rarity of the disease, the rapidity of decline19 
and the industrial nature of the disease, which is associated 
with the need for a legal inquiry by a coroner and protracted 
compensation claims processes.20 The aim of this systematic 
integrative review was to identify and synthesise existing 
evidence on the palliative care needs and experiences of 
people with mesothelioma and their family carers and 
describe how their needs are being addressed.
Methods
Literature review question
The specific question to be addressed was:
What are the palliative care needs and experiences of 
people with mesothelioma and their family carers?
Design
An integrative systematic review methodology was employed 
to enable the inclusion of findings from a diverse range of 
methodologies (i.e. qualitative and quantitative) in this 
•• A co-ordinated, team-based approach to palliative care was preferred, however the majority of the mesothelioma litera-
ture only explicitly recognised palliative care provision when it was provided by specialist palliative care teams and did 
not distinguish between the different levels of palliative care services (i.e. generalist and specialist palliative care).
•• The process of seeking compensation compounds an already difficult situation by dictating how the limited time the 
patient and carer have left together is spent.
Implications for practice, theory or policy
•• Greater consideration of the role non-specialist palliative care clinicians’ play in providing generalist palliative care in 
mesothelioma is required, as well as increased partnership working with specialist palliative care.
•• The unique circumstances regarding compensation in asbestos related disease should be considered an important ele-
ment of palliative care for this group.
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under researched topic.21 The review followed the proce-
dures outlined in the Centre for Reviews and Dissemination 
(CRD) guidance.22 The review protocol is registered in 
PROSPERO: CRD42020190115. The Preferred Reporting 
Items for Systematic Reviews and Meta-Analyses (PRISMA) 
was used as the reporting guideline.23
Search strategy
Electronic searches were undertaken using the following 
databases: MEDLINE, CINAHL, PsycINFO and the Cochrane 
Library. Core search terms included: mesothelioma and 
palliative care or end of life care or terminal care or sup-
portive care or hospice. The search was limited to include 
papers published from 01 January 2000 to 10 May 2020. 
The terms were adapted for each database and MeSH 
terms were used, where possible. Search histories are 
provided in Supplemental Appendix 1. The reference lists 
of included papers were searched for potentially relevant 
articles.
Once duplicates had been removed, the title and 
abstract of all identified records were screened according 
to the inclusion and exclusion criteria shown in Table 1 by 
one reviewer (MH); whilst a second reviewer (CG) inde-
pendently screened 10% of records to ensure the inclu-
sion and exclusion criteria were being applied with good 
agreement. Full-text review was carried by two independ-
ent reviewers (MH and one of CG/SE/BT). Decisions were 
documented in separate databases and disagreements 
were resolved by consensus.
Data extraction, analysis and synthesis
The process of extracting and synthesising the data fol-
lowed the integrative method described by Whittemore 
and Knafl,21 which allows for the synthesis of findings 
from a diverse range of designs (qualitative, quantitative 
and reviews). Data reduction and extraction were con-
ducted by one reviewer (MH) using a pre-defined pro 
forma, including the following: author(s); year of publica-
tion; country where study was conducted; study design; 
population; setting; sample; characteristics of included 
patients (age, sex, time since diagnosis); patients’ pallia-
tive care needs and who identified them; family carers’ 
palliative care needs and who identified them and how 
palliative care needs were being addressed. The process 
of data reduction facilitated the integration of findings 
from a variety of different study designs in which patients’ 
and carers’ palliative care needs were measured and 
reported in different manners.21 Data from the pro forma 
were displayed using a coding matrix in Excel to enable 
comparison on specific issues or sample characteristics. 
Two authors (MH and CG) collaboratively reviewed the 
extracted data noting patterns and themes and drawing 
conclusions through discussion.21
Quality appraisal
All studies included in the analysis were assessed for 
methodological quality. Each assessment was carried 
out by two independent reviewers (MH and one of CG/
SE/BT). Where disagreements arose they were dis-
cussed and resolved through consensus. The Mixed 
Methods Appraisal Tool (MMAT) was used to appraise 
primary research.24 The MMAT can be used to assess 
the methodological quality of five different categories 
of study design. The tool includes two screening ques-
tions to determine whether the study is empirical and 
five quality criteria for each category of study. To 
appraise reviews, the Joanna Briggs Institute (JBI) 
Critical Appraisal Checklist for Systematic Reviews and 
Research Syntheses was used.25 The review checklist 
includes 11 quality criteria. It is not recommended to 
present an overall score when using the MMAT,24 and 
since scoring of quality appraisal has been criticised 
more widely,26 a score will not be presented for the JBI 
review checklist either. The appraisal will instead inform 
a narrative description of study quality and inform the 
weight placed on the findings of different studies in the 
data synthesis. As methodological quality was not 
established as an inclusion or exclusion criteria, all arti-
cles appraised were included in the review.
Table 1. Inclusion and exclusion criteria.
Inclusion criteria Exclusion criteria
Empirical research studies (any research design) or 
comprehensive reviews including information about the 
palliative care needs* and experiences of people with 
mesothelioma and their family carers
Not focused on people with mesothelioma/data from people 
with mesothelioma not presented separately
  No reference to the palliative care needs* or experiences of 
patients and families
  Conference proceedings/discussion articles/commentary/
letters/book chapters without a comprehensive literature review
  Published in a language other than English
*Palliative care need was defined as the capacity to benefit from palliative care.
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Results
A total of 508 articles were initially retrieved and 14 met 
the inclusion criteria. The PRISMA flow diagram in Figure 1 
illustrates the article selection process and reasons for 
exclusion.
Study characteristics
Table 2 shows a summary of the characteristics of the 
included studies along with a summary of the main find-
ings relevant to this review. The included studies used a 
variety of different methodologies: quantitative (n = 8), 
qualitative (n = 5) and review (n = 1). The majority of 
studies were conducted in the UK (n = 6) or Australia 
(n = 5), with others from Japan (n = 2), Italy (n = 1) and 
the United States (n = 1). Sample sizes ranged from 2 
patients in one of the qualitative studies27 to 174 patient 
participants in a multi-centre randomised controlled 
trial.17 Most articles exclusively included people with 
mesothelioma (n = 11) and their carers (n = 5), the oth-
ers included: nursing staff,28 mesothelioma and asbes-
tos related lung cancer (but all patient participants had 
mesothelioma),27 and a review that compared the psy-
chological care needs of patients with mesothelioma 
and advanced lung cancer.29 The majority of articles 
were limited to people with malignant pleural mesothe-
lioma (n = 10), whilst the others were open to people 
with all types of mesothelioma (n = 3). All of the studies 
that reported the gender of the participants included 
more males than females, as would be expected given 
the higher prevalence of mesothelioma in men. Where 
reported, the average age of patient participants ranged 
from 5130 to 73 years.31









Table 2. Summarised results of the studies assessed in this systematic review.
First author, country 
and year
Study aim Study design and 
methodology
Population, setting and sample size Main findings
Arber and Spencer32 
UK, 2013
To explore the patient’s 
experience during the first 
3 months following a diagnosis of 
malignant pleural mesothelioma 
(MPM)
Qualitative MPM patients recruited from two 
hospitals
The key concept was ‘uncertainty and lack of control’, which was underpinned by three themes: 
it’s all bad news, good days and bad days and strategies of amelioration.
Grounded theory N = 10 Participants described worries about long-term outcome and speed of deterioration even in the 
early stage after diagnosis. One participant described seeking referral to palliative care. Palliative 
care referral was a positive experience/turning point. Patients’ lack of control was added to by 
not understanding who was in charge of their care.
Ball et al.29 UK, 2016 To establish whether the 
psychological needs of patients 
with pleural mesothelioma 
are the same as patients with 
advanced lung cancer
Review 17 articles, including five with MPM 
patients only and nine with advanced 
lung cancer only and three mixed 
MPM and lung cancer
Common themes across the studies were grouped into 10 key concepts: these were uncertainty, 
normality, hope/hopelessness, stigma/blame/guilt, family/carer concern, physical symptoms, 
experience of diagnosis, iatrogenic distress, financial/legal and death and dying.
Meta ethnography N = unknown Lack of referral to specialist palliative care and supportive care provision was noted as a particular 
issue for those with MPM. Those with MPM expressed concern about death and the process of 
dying. As well as the need to ensure their affairs were in order to reduce the burden on family.
Bibby et al.33 UK, 2017 To describe the characteristics 
of patients who chose active 
symptom control over 
chemotherapy and explore their 
reasons for doing so
Quantitative MPM patients recruited from one 
hospital
Active symptom control was chosen by 33% of participants. Participants choosing active symptom 
control were older, had poorer performance status and were more often female. Reasons for 
choosing active symptom control included: benefits of chemotherapy did not justify the risk of 
side effects (5/15), a desire to prioritise quality of life in the context of no current symptoms 
(4/15), needle/hospital phobia (3/15), prior negative experiences of chemotherapy (2/15), 
pursuit of experimental treatment in another country (1/15). Reasons were only documented for 




Brims et al.17 Australia 
and UK, 2019
To examine the effect of regular 
early specialist palliative care 
on HRQoL in patients with MPM 
and their carers compared with 
standard care alone
Quantitative MPM patients and their carers 
recruited from 19 UK hospitals and 
one large Australian site
Routine early referral to specialist palliative care did not result in a statistically significant 
difference in quality of life or mood at 12 and 24 weeks post-randomisation for patients with a 
good performance status when compared to standard care alone. Carer satisfaction with end-of 
life care was measured using the FAMCARE-2 questionnaire. Scores were significantly higher 
in the intervention arm at 12 and 24 weeks indicating that routine early referral to specialist 





Clayson et al.34 UK, 
2005
To describe the experience of 
mesothelioma and its meaning 
for patients
Qualitative MPM patients recruited from three 
hospitals
The findings were described across four themes: coping with symptoms, the burden of 
medical interventions, finding out about mesothelioma and psychosocial issues. The offer of 
palliative care from a Macmillan nurse at the time of diagnosis was distressing and provoked 
fear. Symptom burden provided a constant reminder of disease progression. Some patients 
demonstrated acceptance of the terminal nature of the diagnosis, others made plans to deal with 
their death and possessions. The benefit and compensation process aggravated the situation and 
persists for relatives after the patients die.
Grounded theory N = 15
Dooley et al.30 
Australia, 2010
To investigate the specific 
psychological consequences of 
mesothelioma
Quantitative Mesothelioma patients recruited via a 
lawsuit filed against their employer
People with mesothelioma reported higher levels of depression and anxiety and significantly 
more traumatic stress symptoms than the normative group for the Trauma Symptom Inventory. 
The symptom cluster related to the re-experiencing domain suggests that the physical 
manifestation of the illness served as a constant reminder of health status. Clinical interviews 





















First author, country 
and year
Study aim Study design and 
methodology
Population, setting and sample size Main findings
Hughes and Arber35 
UK, 2008
To explore patients’ lived 
experience of mesothelioma
Qualitative MPM patients recruited from local 
palliative nursing service (Macmillan) 
referrals
Six themes were identified: physical effects, loss of intimacy, isolation, pursuing compensation, 
sharing experiences and supportive care. The majority of supportive care was sought out by 
patients from GPs, specialist palliative care or psychological services. Participants wanted the 
right support at the right time and suggested that they could not take in information about 
supportive/palliative care in the early stages due to the overwhelming amount of information 
provided. Pursuing compensation dictates how limited time together is spent and requires a joint 
effort between the patient and carer.
Phenomenological 
approach
N = 5 Carer’s need the opportunity to speak with healthcare professionals in confidence, alone.
Kao et al.31 Australia, 
2013
To determine the proportion 
of MPM patients who received 
active anticancer treatments in 
the last month of life and identify 
potential factors associated with 
chemotherapy use
Quantitative MPM patients recruited from 
compensation scheme (Dust Diseases 
Board of New South Wales)
Patients who received two or more lines of chemotherapy were more likely to be receiving 
chemotherapy in their last month of life. Patients who received chemotherapy at the end of life 
had shorter survival compared to those who did not receive chemotherapy at the end of life. 
Authors suggest careful consideration of when to cease chemotherapy is required, including 
timely and frank discussion with the patient and their family. There was a trend for lack of 




Lee et al.36 Australia, 
2009
To describe the needs and 
experiences of people with 
mesothelioma and asbestos-
related lung cancer, their carers 
and service providers in the 
Latrobe Valley community
Qualitative Patients with mesothelioma and 
asbestos related lung cancer, carers 
and healthcare/legal professionals 
recruited from advertisements
Three main themes: illness experience, carer and family roles and services and service gaps. 
Referral to palliative care occurred late in the illness due to discomfort associated with 
acknowledgement of dying, which resulted in poor symptom control and a lack of support for 
carers. A lack of holistic and co-ordinated care was described, as well as difficulty accessing 
reliable and accurate information. The effort and time required to seek compensation was 
particularly burdensome given the declining health of the patients.
Descriptive case study Mesothelioma patients N = 2 Carers expressed concerns about the lack of bereavement services. One carer described palliative 
care nurses as ‘the angels of death’.Carers N = 6
Professionals N = 5
Mercadante et al.37 
Italy, 2006
To examine the epidemiological 
characteristics and symptom 
burden of mesothelioma patients 
when admitted to home palliative 
care
Quantitative Mesothelioma patients recruited 
from a home palliative care service
Patients had a consistently high physical and psychological symptom burden (depression and 
anxiety). Three quarters of patients had pain (18 moderate, 2 severe) despite receiving high 
doses of opioids. The principal pain site was the chest. Pain was significantly associated with 
the amount of oral morphine delivered and dyspnea. The average duration of home palliative 
care admission was 54.8 days (which corresponded with death for all except two participants). 





Nagamatsu et al.28 
Japan, 2014
To evaluate the effect of both the 
Educational Program on Palliative 
Care for Patients with MPM 
and the Palliative Care for MPM 
Handbook for Nurses in Japan
Quantitative Nursing staff recruited nationwide 
from hospitals, home visiting nurse 
stations and health care centres
The educational program on palliative care for MPM for nurses was effective in reducing 
perceived difficulties experienced by nurses caring for patients with MPM. Post-test difficulty 
scores were lower than the pre-test scores. Participants positively evaluated the educational 
program for validity, clarity, clinical usefulness and the facilitators. Quotes from the evaluation 
provided information about the educational needs of staff to enable them to meet the palliative 
care needs of mesothelioma patients: physicians lack of knowledge about what medicines to 
prescribe; the lack of information/handbooks on the topic; the desire to learn more about 














First author, country 
and year
Study aim Study design and 
methodology
Population, setting and sample size Main findings
Nagamatsu et al.38 
Japan, 2019
To determine the needs of 
patients within the health service 
by quantifying the requests to 
their physicians and qualitatively 
analysing their responses
Quantitative MPM patients recruited nationwide 
from cancer hospitals and support 
groups
Patients with MPM had a variety of unmet needs from their physicians. Patients wanted clear and 
understandable explanations about MPM, particularly in relation to the curability and prognosis 
of the disease. Participants wanted their physician to deliver treatment based on the patient’s 
perspective by accepting and empathising with their anxiety and pain. Physicians conveying 
information about the benefits of palliative care and advising the patient to introduce it at an 
early stage was perceived to be helpful as it gave the patient time to prepare. Patients who did 
not receive palliative care made more physician requests than those who received palliative care.
Retrospective survey N = 73
Walker et al.39 United 
States, 2019
To explore the lived experience 
of MPM in the United States and 
identify unmet patient needs
Qualitative MPM patients recruited from 
University Medical Centre
Three major themes: uncertainty/worry about the future, value in relationships and adapting 
to a new norm. Uncertainty/worry about the future stemmed from a lack of clarity about when 
the MPM would progress and how or when death would occur. Awareness of the incurable 
nature of the condition was referred to as a ‘death sentence’, and the most common coping 
strategy was ‘taking life one day at a time’. Some employed practical strategies by making 
advanced preparations. Patients expressed concern about symptom management at the end of 
life, particularly in relation to pain and breathlessness. MPM patients preferred a personalised, 
coordinated, team based approach with open and honest communication. Worries about loss 
of control at the end of life were expressed. Spiritual or religious rituals and support helped 




Warby et al.9 Australia, 
2019
To document the experience 
of MPM patients and their 
caregivers
Quantitative MPM patients and their informal 
carers recruited from support groups 
nationwide, a regional compensation 
scheme and advertisements in two 
hospitals
A palliative care referral had been received by 31% of patients, compared to 85% of caregivers 
(many were bereaved). Of the patients who had not received palliative care, none felt it could 
have helped them, but 13% of carers whose patients did not receive palliative care felt it could 
have helped them. The majority of participants received ‘sufficient’ support (71%). Thirty-five 
percent of patients would have liked more information about what to expect with their disease. 
Almost all patients sought compensation for their MPM (97%).
Retrospective survey Patients N = 78 Caregivers would have liked to talk to someone by themselves (41%), more time with doctors 
(30%), access to psychological support (29%) and clearer information (31%). Bereaved caregivers 
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Methodological quality
Overall, the methodological quality of the included studies 
was moderate to high (see Supplemental Appendices 2 and 
3). The qualitative studies included were generally of high 
methodological quality, but there was a lack of information 
about sampling strategies and little justification of sample 
size,32,34,35,36,39 which ranged from 227 to 1534 participants 
with mesothelioma. The quantitative descriptive studies 
sometimes failed to ensure the sample was representative 
of the target population due to recruitment through com-
pensation claims9,31 and lawsuits.30 However, studies recruit-
ing through clinical caseloads had small sample sizes due to 
the rarity of the condition.37 Response rates across the 
descriptive studies were relatively low increasing the chance 
of non-response bias.9,31,38 The only randomised controlled 
trial was methodologically sound, but it was not possible to 
blind participants or the research team to group allocation 
due to the nature of the palliative care intervention.17 One 
of the quantitative non-randomised studies was methodo-
logically sound,33 but the other attempted to evaluate effec-
tiveness without a control group and did not account for any 
confounding factors.28 The only systematic review to be 
included in the review lacked a clear search strategy.29
Main findings and key themes
The synthesis highlighted one cross cutting theme of 
‘uncertainty’ and five themes within this: (1) organisation 
and co-ordination of services, (2) communication and 
information needs, (3) management of care needs and 
high symptom burden, (4) consideration of the impact of 
seeking compensation and (5) family carer needs. Each of 
the five themes will be described in turn.
Organisation and co-ordination of services
The cross-cutting theme of uncertainty was described in 
relation to the diagnosis, prognosis and progression of mes-
othelioma across a number of qualitative studies,32,34,39 and 
a qualitative review.29 This uncertainty and loss of control 
was compounded when patients also did not know who was 
co-ordinating their care. Care was described as fragmented 
and uncoordinated,29 with patients ‘bewildered’ by various 
doctors34 and patients left feeling that they were navigating 
the system on their own.27 In addition, patients not receiv-
ing active anticancer therapy reported feeling abandoned 
by the system.35 Communication between hospital and 
community services was criticised in qualitative studies27,35 
and a survey found communication between healthcare 
professionals was perceived to be variable, with 25% of 
patients stating that their health professionals talked to 
each other occasionally or hardly ever.9 Studies have high-
lighted the need for people with mesothelioma to receive a 
co-ordinated, team-based approach to palliative care, whilst 
recognising that they need a named point of contact to 
provide some certainty about who is in charge of their 
care.29,32,34,39
When describing the organisation of palliative care ser-
vices for people with mesothelioma, studies often lacked 
clarity in terms of what they meant by palliative care, with 
few studies making a clear distinction between generalist 
and specialist palliative care.17 However, the language used, 
such as ‘referral’ or ‘access’ to palliative care,9,27,31,32,35,37 
demonstrate an underlying assumption, from authors and 
patient participants, that palliative care is provided by a 
separate, specialist team rather than by existing members 
of the patients clinical team. A number of articles made rec-
ommendations about the availability of palliative care sug-
gesting early,31,32,37 timely27,34,35 or more equitable9 access 
is needed. Routine early referral of patients with mesothe-
lioma to specialist palliative care was evaluated in a ran-
domised controlled trial, which found that it was not 
effective at improving quality of life or mood in patients 
with good performance status compared with standard 
care.17 Other studies recommending early referral to (spe-
cialist) palliative care provided this suggestion on the basis 
of qualitative reports of patients having to independently 
seek out a palliative care referral32,35 and poor pain man-
agement prior to referal.37 Additionally, lack of palliative 
care input was found to be associated with patients 
expressing more suggestions for improvements in their 
medical care38 and increased likelihood of receiving chemo-
therapy in the last month of life (which represents poor 
oncology practice).31 However, it is important to note that 
in this review the need for early referral was not expressed 
directly by patients or clearly indicated by the findings. A 
recent survey conducted in Australia found that, of the 
patients who had not received palliative care, none felt that 
it could have helped them, whereas 13% of carers thought 
it would have been helpful.9 Offering a palliative care refer-
ral at the time of diagnosis when patients felt overwhelmed 
with new information was perceived to be distressing in 
two qualitative studies.34,35
In contrast, a more recent qualitative study shifts the 
emphasis from specialist palliative care referral to the role 
that nursing staff can play in providing supportive care (a 
term often used synonymously with palliative care).39 
Nurses are recommended to support patients with malig-
nant pleural mesothelioma to find meaning in their lives and 
encourage strategies for adapting to a ‘new norm’, as well as 
promoting control through healthy lifestyle choices, autono-
mous decision making and spiritual practices.39 This is con-
sistent with a suggestion from another study that supportive 
care could be provided via an early opportunity for a home 
visit with a clinical nurse specialist or specialist palliative 
care nurse.32 Where patients described the palliative care 
they had received, it was viewed as beneficial as it provided 
an opportunity to discuss their anxieties and help them to 
feel more prepared.32,35,38
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Communication and information needs
Most of the articles included in the review (n = 9) 
described difficulties in accessing information to enable 
people with mesothelioma to make informed treatment 
decisions and/or poor communication practices between 
healthcare professionals and patients.27–29,31,32,35,38,39 The 
information and communication needs highlighted were 
described in relation to patients whole care experience, 
including palliative care, but not necessarily specifically 
about palliative care. Studies highlighted difficulties 
accessing reliable and accurate information,27 and clear, 
understandable explanations.38,39 Patients also wanted 
to have an opportunity to express their illness story and 
valued the opportunity to be listened to by a healthcare 
professional; demonstrating the importance of two-way 
communication.32,35 Two studies highlighted the impor-
tance of developing relationships with other people with 
mesothelioma and a need to share their experiences 
with others in a similar position, where this was not 
available.35,39
The need for open and frank communication when 
conveying information about the curability, prognosis and 
progression of the disease was highlighted across multiple 
studies.9,31,38,39 In one survey, 35% of patients would have 
liked more information about what to expect from their 
disease, whilst 58% of carers would have liked more infor-
mation about what to expect in caring for someone with 
malignant pleural mesothelioma.9 A survey in Japan, 
found that whilst most participants (n = 17) wanted clear 
and complete information about their disease and its 
prognosis, a smaller number (n = 5) wanted the informa-
tion to be delivered in a more indirect or vague manor.38 
These differences highlight the importance of a personal-
ised approach to communication and information provi-
sion, which was also recommended in a recent qualitative 
study.39 In the same study, patients highlighted that they 
would like more information about how and when death 
might occur.39 The lack of clear information exacerbated 
feelings of uncertainty.29,39
Information provision was perceived to be the role of 
healthcare professionals with one article describing the 
importance of staff being knowledgeable about mesothe-
lioma and dedicated to its treatment.38 Walker et al.39 
emphasise the key role that nursing staff play in communi-
cation by assessing information needs and providing per-
sonalised education. One article described an evaluation 
of an educational program on palliative care for patients 
with malignant pleural mesothelioma for nurses in Japan.28 
Nurse participants were highly satisfied with the program 
and its handbook and the evaluation suggested that the 
training reduced perceived difficulties experienced by 
nurses caring for people with mesothelioma. Quotes high-
lighted a desire to learn more about communicating with 
dying patients; lack of resources about how to provide pal-
liative care for people with mesothelioma and concerns 
around health care professional’s knowledge of how to 
control symptoms and what medicines to prescribe.28
Management of care needs and high 
symptom burden
The high symptom burden experienced by people with 
mesothelioma was widely described across the included 
articles.17,27,28,30,32,33–35,37–40 Mercadante and colleagues 
observed that patients had a consistently high physical 
and psychological symptom burden with patients scoring 
a mean sum of 37.7/100 on the Edmonton Symptom 
Assessment System at admission to home palliative care.37 
A high prevalence of pain, weakness, poor appetite, poor 
well-being and dyspnea were noted.37 Three quarters of 
patients had pain (18 moderate, 2 severe) on admission 
despite having received high doses of opioids; pain was 
found to be associated with the amount of oral morphine 
delivered and dyspnea.37 Patients earlier in the disease 
trajectory expressed fears of uncontrolled pain,39 short-
ness of breath/suffocation34,39 and the process of dying,29 
whereas those interviewed later in the trajectory rede-
fined the meaning of their symptoms as the disease devel-
oped.34 The heavy symptom burden provided a constant 
reminder of disease progression and health status.30,34 
The poor prognosis related to mesothelioma caused a 
dilemma for patients about whether to initiate and/or 
continue treatment given the limited gains offered and 
the considerable side effects associated with treat-
ment.32,33 An observational study conducted in a single UK 
centre found 33% of people with mesothelioma chose 
active symptom control; the primary reasons for declining 
anti-cancer treatment were concerns over side effects, 
the modest survival benefit and previous negative chemo-
therapy experiences.33 Those choosing active symptom 
control were older (mean age 74 vs 68), had a poorer per-
formance status and were more often female (24% vs 
11%).33 Open and frank communication between physi-
cian and patient about when to cease chemotherapy was 
recommended, as it was found that patients who received 
chemotherapy at the end of life had shorter survival com-
pared to those who did not.31 Furthermore, there was a 
non-significant trend for patients to die in their usual resi-
dence if they did not receive chemotherapy in the last 
month of life.31
Uncertainty and lack of control resulting from the 
incurable nature of the disease, lack of clarity around dis-
ease progression and when death would occur was per-
ceived to be a primary cause of the emotional and 
psychosocial distress associated with mesothelioma.29,32,39 
This was illustrated by descriptions of the diagnosis as a 
‘death sentence’39 and narratives of existential distress 
relating to ‘loss of control not only of the body, but also of 
one’s life’.32 A qualitative review identified a theme of 
hopelessness across three mesothelioma studies due 
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to the incurable nature of the disease and limited 
prognosis,29 whereas other studies noted acceptance of 
the terminal nature of the illness34 and hope for a cure or 
short/long term survival.39 Psychological symptoms 
described included depression, anxiety and traumatic 
stress symptoms.30,37 Coping strategies employed by peo-
ple with mesothelioma included: ‘taking life 1 day at a 
time’39; engaging with spiritual or religious rituals and 
support39; focusing on making the best use of time left34 
and exploring fears and anxieties with a health care pro-
fessional.32,35 Furthermore, some articles described 
patients employing practical strategies such as putting 
their financial affairs in order to make the future more 
predictable, or to reduce the burden on family.29,34,39
Consideration of the impact of seeking 
compensation
As a disease commonly caused by occupational exposure to 
asbestos, most people with mesothelioma are eligible for 
compensation. An Australian survey, that included a com-
pensation scheme as a source of recruitment, found that 
97% of participants sought compensation and most partici-
pants had learned compensation might be an option from a 
doctor (62%).9 For one patient, who received information 
about seeking compensation at the time of diagnosis, it was 
perceived that this was too early as they were overwhelmed 
by information at that time.32 The main reasons described 
for seeking compensation were to ‘leave their family finan-
cially secure’ (67%), for ‘justice’ (59%) and because they 
‘needed money to help with treatment costs’ (30%).9 As an 
industrial disease, one study found that patients wanted 
their doctors to view them as a victim of asbestos,38 whereas 
another described the dilemma of whether to seek com-
pensation from a longstanding employer to whom they felt 
significant loyalty.27 Several qualitative studies described 
how the additional burden of seeking compensation aggra-
vated an already difficult situation.27,29,34,35 The terminal 
nature of the diagnosis meant that what limited time the 
patient had left had to be spent meeting lawyers, complet-
ing forms and finding relevant documents and evidence of 
asbestos exposure.29 Furthermore, due to the high symp-
tom burden of the disease it was described that seeking 
compensation had to be a joint effort between the patient 
and carer, as there are times when the patient was too 
unwell to pursue the claim.35 Moreover, whether or not 
they would actually receive the compensation was another 
source of uncertainty.34
Family carer needs
The needs of family carers were described in four of the 
included papers.9,17,27,33 The only randomised controlled 
trial included in the review identified that routine early 
referral to specialist palliative care significantly improved 
carer satisfaction compared to usual care.17 Specifically 
there was increased satisfaction reported with the emo-
tional support provided to family members by the special-
ist palliative care team, as well as other items related to 
how the carer perceived care was provided to the patient 
in terms of: attention to symptoms, management of 
symptoms, response to symptom changes and emotional 
support.17 A survey identified that 31% of carers would 
have liked clearer information about malignant pleural 
mesothelioma9 and a qualitative study highlighted the 
need for information around intimacy as symptoms pro-
gressed.35 Moreover, family carers would have liked the 
opportunity to talk to a healthcare professional by them-
selves,9,35 more time with doctors and access to psycho-
logical support.9 In the studies that included bereaved 
relatives of people with mesothelioma, concerns were 
expressed about the lack of bereavement services; 
bereaved relatives felt they would have benefitted from 
grief counselling and/or a post-death consultation with a 
medical or palliative care specialist.9,27
Discussion
This systematic integrative review presents an overview of 
the palliative care needs of people with mesothelioma 
and their families. The studies revealed a wide range of 
palliative care needs including the need for a co-ordi-
nated, team based approach to palliative care, open and 
frank communication around the curability, prognosis and 
progression of the disease and the opportunity for 
patients and carers to explore their fears and anxieties 
and prepare themselves for the end of life both emotion-
ally and practically. In addition, the process of seeking 
compensation compounds an already difficult situation by 
dictating how the limited time the patient and carer have 
left together is spent. Studies detailing the needs of family 
carers found they would like the opportunity to speak 
with a healthcare professional alone and bereaved rela-
tives felt they would have benefitted from grief counsel-
ling or a post-death consultation with a doctor.
Evidence from our review suggests people with meso-
thelioma and their family carers report a wide range of pal-
liative care needs, yet conflicting statements have been 
reported regarding the benefit of specialist palliative care 
for these patients (e.g. Brims et al.17 and Kao et al.31). This 
may be the result of specialist palliative care services being 
unable to meet the complex and unique needs of people 
with mesothelioma. However, perhaps an alternative 
explanation is that the provision of ‘generalist’ palliative 
care, by providers already highly skilled in caring for people 
with mesothelioma, is sufficient to meet the palliative care 
needs of these patients. Further exploration of the role of 
thoracic and oncology teams in providing palliative care, 
and the potential for working in partnership with specialist 
palliative care, is needed to better understand how to meet 
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the complex needs of this patient group. Indicative of the 
importance of this, a study exploring healthcare profession-
als perceptions of caring for people with mesothelioma 
found 74% of nurses perceived one of their main functions 
was interacting with palliative care services.40
Compared with other cancers, this integrative review 
confirms some notable differences in the palliative care 
needs of people with mesothelioma, such as legal and 
compensation issues, which are almost unique to this 
patient group and present challenges that health profes-
sionals may not be familiar with addressing. A growing evi-
dence base suggests that patients approaching the end of 
life and their family carers can face considerable financial 
burden,41 and this burden can have negative implications 
for both patient and carer. For people with mesothelioma, 
there is a difficult trade-off between financial security and 
long winded, complex compensation claims. The impact of 
this on patients and carers should be acknowledged, and 
the unique circumstances regarding compensation in 
asbestos related disease should be considered an impor-
tant element of palliative care for this group.
The cross-cutting theme of uncertainty underpinned 
the other themes relating to the patients’ needs. Similarly 
to this study, others have noted that uncertainty at the 
end of life is often a source of distress, however unlike 
other populations uncertainty was less commonly dis-
cussed in relation to spirituality,42 but was primarily 
related to medical prognosis and when death would occur. 
As others have proposed, our findings support the impor-
tance of healthcare professionals discussing uncertainty 
with patients and their carers.43 Furthermore, uncertainty 
compounded by lack of co-ordinated care could be allevi-
ated by a co-ordinated team based approach to palliative 
care with a named point of contact. This reflects the rec-
ommendations of the British Thoracic Society, who stress 
the importance of co-ordinated care facilitated by clinical 
nurse specialists and recommend a named point of con-
tact in case of need.14
The palliative care needs of family carers of people 
with mesothelioma were only described in five of the 
included studies. Similarly to the carers of patients with 
other terminal diagnoses, carers of people with mesothe-
lioma highlighted the need for more care-related informa-
tion and psychological support.44 Tools such as the Carer 
Support Needs Assessment Tool (CSNAT), which is widely 
used in palliative care, could be adopted in mesothelioma 
care as one means of assessing carer needs and directing 
to appropriate support.45 The need for carers of people 
with mesothelioma to receive one-to-one support from 
health care professionals, has also been highlighted in a 
review exploring the psychological needs associated with 
mesothelioma.10 The need for bereavement support, such 
as grief counselling or a post-death consultation identified 
in this review,9,27 is widely acknowledged but accessing 
support can be challenging.46
Strengths and limitations
One potential limitation is that we may have overlooked 
relevant studies; however, we believe this to be unlikely 
given the rigorous search strategies and manual searching 
of included papers reference lists. Whilst all of the 
included articles detail the palliative care needs of people 
with mesothelioma, the primary focus of many of the arti-
cles was not palliative care, but the experience of meso-
thelioma more broadly, which limited the depth of the 
findings. Another possible limitation is the heterogeneity 
of the included studies, which can present a challenge in 
terms of synthesising findings generated by different 
methodologies of varying qualities. The integrative review 
methodology employed in the review enhances the rigour 
of the synthesis process and ensures relevant information 
is not overlooked.21 The main strength of this review is 
that it is the first systematically conducted review in this 
under-researched topic area. The search was comprehen-
sive and the integrative review methodology enabled the 
synthesis of findings from a wide range of study designs.
What this review adds
As the first systematic review of the palliative care needs 
and experiences of people with mesothelioma and their 
families our findings have important implications for both 
clinical practice and research. The review demonstrates 
an overall dearth of evidence for this challenging and rare 
cancer. Our findings indicate that people with mesotheli-
oma report a range of palliative care needs which need to 
be understood within the context of their diagnosis. The 
unique combination of mesothelioma being a rare cancer 
and an industrial disease means that healthcare profes-
sionals need to pay particular attention to the impact the 
process of seeking compensation has on people with mes-
othelioma and carers throughout their palliative journey. 
Understanding these unique circumstances should be 
central to a co-ordinated, team-based approach to pallia-
tive care with a named point of contact.
This review also adds to the broader debate about how 
to provide palliative care for a growing population of 
patients with palliative care needs, within a system lim-
ited by resources and with specialist palliative care capac-
ity unlikely to see significant expansion. The provision of 
‘generalist’ palliative care by a wider range of health and 
social care professionals has been posed as one solution 
to this issue, yet many non-specialists feel they lack the 
requisite skills to provide this care.47 Findings from our 
review support the notion that palliative care needs are 
often complex and, particularly in a rare cancer like meso-
thelioma, some generalists lack confidence in addressing 
these needs. The future development of palliative care 
services for people with mesothelioma and their carers 
will require better systematisation of the levels of care 
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provision, as well as exploration of the potential for more 
partnership working between generalist and specialist 
palliative care providers. The findings support the need to 
further understand of the role that clinical nurse special-
ists play in the delivery of palliative care for rare cancers.48 
Recent evidence suggests that specialist/advance practice 
nurses can play an instrumental role in improving the end 
of life care experience, and are well positioned to address 
the shortfall of palliative care expertise.49 A better under-
standing of the role of clinical nurse specialists in palliative 
care for mesothelioma will allow us to draw wider implica-
tions for other life limiting conditions.
Understanding of this topic would benefit from an in-
depth qualitative exploration focussed specifically on the 
palliative care needs experienced by people with meso-
thelioma and their family carers. In addition, further 
research exploring the quality and content of generalist 
palliative care currently being provided by healthcare pro-
fessionals would help to unpick the conflicting findings 
relating to the benefits of early referral to specialist pallia-
tive care.
Conclusion
This study demonstrates that people with mesothelioma 
and their carers have a wide range of palliative care needs. 
The needs of patients and carers were underpinned by a 
cross-cutting theme of uncertainty and categorised into 
five areas of need/themes: (1) organisation and co-ordi-
nation of services, (2) communication and information 
needs, (3) management of care needs and high symptom 
burden, (4) consideration of the impact of seeking com-
pensation and (5) family carer needs. Studies including 
family carers described the need for one-to-one support 
for carers from a healthcare professional, access to care-
related information and psychological support, as well as 
bereavement support. The conflicting findings around the 
importance of early referral to specialist palliative care 
warrants further investigation into partnership working 
and the role thoracic and oncology teams play in provid-
ing generalist palliative care.
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